Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |